OpenSecrets.org @OpenSecretsDC
A bipartisan team of senators introduced a bill to provide increased access to generic drugs. But amid intense lobbying from the pharmaceutical industry, it was withdrawn to undergo changes https://t.co/t2fxpdRMVI by @jsscppr — PolitiTweet.org